NewslettersDermal Cell NewsUncategorizedTargeting mTOR Signaling Overcomes Acquired Resistance to Combined BRAF and MEK Inhibition in BRAF-Mutant MelanomaBy Justin.choi - July 26, 2021012In vitro experiments showed that a subset of combination therapy melanoma cells was sensitive to mTORC1 inhibition.[Oncogene]Sorry, but the selected Zotpress account can't be found.Full Article